Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lyell Immunopharma (LYEL) Return on Assets (2021 - 2025)

Historic Return on Assets for Lyell Immunopharma (LYEL) over the last 5 years, with Q3 2025 value amounting to 0.83%.

  • Lyell Immunopharma's Return on Assets fell 5300.0% to 0.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83%, marking a year-over-year decrease of 5300.0%. This contributed to the annual value of 0.54% for FY2024, which is 2700.0% down from last year.
  • Latest data reveals that Lyell Immunopharma reported Return on Assets of 0.83% as of Q3 2025, which was down 5300.0% from 0.83% recorded in Q2 2025.
  • Lyell Immunopharma's Return on Assets' 5-year high stood at 0.17% during Q3 2021, with a 5-year trough of 0.83% in Q2 2025.
  • Its 5-year average for Return on Assets is 0.35%, with a median of 0.23% in 2023.
  • Per our database at Business Quant, Lyell Immunopharma's Return on Assets surged by 200bps in 2023 and then crashed by -5300bps in 2025.
  • Over the past 5 years, Lyell Immunopharma's Return on Assets (Quarter) stood at 0.18% in 2021, then decreased by -2bps to 0.19% in 2022, then plummeted by -54bps to 0.29% in 2023, then tumbled by -108bps to 0.6% in 2024, then plummeted by -37bps to 0.83% in 2025.
  • Its Return on Assets was 0.83% in Q3 2025, compared to 0.83% in Q2 2025 and 0.74% in Q1 2025.